Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
South Korea · Delayed Price · Currency is KRW 505,000
+1,000 (0.20%)
Apr 10, 2026, 3:30 PM KST
Sam Chun Dang Pharm. Market Cap
Sam Chun Dang Pharm. has a market cap or net worth of 11.75 trillion as of April 10, 2026. Its market cap has increased by 163.85% in one year.
Market Cap
11.75T
Enterprise Value
11.77T
Revenue
231.81B
Ranking
n/a
PE Ratio
2,232.16
Stock Price
505,000.00
Market Cap Chart
Since September 11, 2001, Sam Chun Dang Pharm.'s market cap has increased from 3.32B to 11.75T, an increase of 353,672.07%. That is a compound annual growth rate of 39.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 11.72T | 116.77% |
| Dec 30, 2025 | 5.41T | 56.57% |
| Dec 30, 2024 | 3.45T | 96.33% |
| Dec 28, 2023 | 1.76T | 82.00% |
| Dec 29, 2022 | 966.58B | 1.04% |
| Dec 30, 2021 | 956.65B | -47.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.14T |
| Celltrion | 44.07T |
| ALTEOGEN | 19.80T |
| Samsung Epis Holdings | 12.86T |
| ABL Bio | 8.71T |
| SK Biopharmaceuticals | 7.64T |
| HLB Co., Ltd. | 7.43T |
| Yuhan | 6.97T |